From genome to prevention plan: what screening really tells you

A genetic report is not a prophecy. It is a set of probabilities, and the single most common failure in this field is handing someone a beautifully designed PDF full of risk percentages and no idea what to do on Monday morning.

Predisposition is not destiny. A variant that raises your relative risk of a condition tells you where to watch and where to act — it does not tell you that the condition is coming. The value is entirely in the translation.

So the questions we ask of your results are practical ones. Which markers should we now be tracking, and how often? Which therapies move to the front of your plan? Where does your metabolism differ enough from the average that standard advice will fail you? What is worth screening for earlier than the population guidelines suggest?

And one commitment that should be non-negotiable at any clinic you trust: your raw genetic data remains yours. It is never sold, licensed, or shared.